| 9th Jun 2023 7:05 am |
RNS |
nirsevimab recommended for infant RSV protection |
| 9th Jun 2023 7:00 am |
RNS |
AstraZeneca agreement with Quell Therapeutics |
| 2nd Jun 2023 5:00 pm |
RNS |
Imfinzi improved pCR in gastric and GEJ cancers |
| 1st Jun 2023 3:05 pm |
RNS |
Block listing Interim Review |
| 1st Jun 2023 3:00 pm |
RNS |
Total Voting Rights |
| 1st Jun 2023 7:00 am |
RNS |
Lynparza approved in US for BRCAm prostate cancer |
| 26th May 2023 7:00 am |
RNS |
Imfinzi + Lynparza prolonged PFS in endometrial ca |
| 22nd May 2023 7:05 am |
RNS |
Directorate Change |
| 17th May 2023 7:00 am |
RNS |
Tagrisso plus chemo improved PFS in lung cancer |
| 9th May 2023 11:00 am |
RNS |
Director/PDMR Shareholding |
| 9th May 2023 7:00 am |
RNS |
Farxiga extended in the US for heart failure |
| 2nd May 2023 3:00 pm |
RNS |
Total Voting Rights |
| 2nd May 2023 10:00 am |
RNS |
Director/PDMR Shareholding |
| 2nd May 2023 7:00 am |
RNS |
ODAC vote on Lynparza combo in prostate cancer |
| 27th Apr 2023 5:30 pm |
RNS |
Result of AGM |
| 27th Apr 2023 7:05 am |
RNS |
Board Committee Changes |
| 27th Apr 2023 7:00 am |
RNS |
1st Quarter Results |
| 26th Apr 2023 4:45 pm |
RNS |
Director Declaration |
| 11th Apr 2023 7:00 am |
RNS |
Update to arrangements with Sobi and Sanofi |
| 5th Apr 2023 7:00 am |
RNS |
Lynparza + Imfinzi met endpoint in ovarian cancer |
| 3rd Apr 2023 3:00 pm |
RNS |
Total Voting Rights |
| 3rd Apr 2023 7:00 am |
RNS |
Ultomiris recommended for NMOSD EU approval |
| 30th Mar 2023 7:00 am |
RNS |
AstraZeneca completes KYM agreement for CMG901 |
| 27th Mar 2023 11:00 am |
RNS |
Director/PDMR Shareholding |
| 22nd Mar 2023 11:00 am |
RNS |
Notice of AGM |
| 9th Mar 2023 7:00 am |
RNS |
Imfinzi improved EFS in resectable lung cancer |
| 8th Mar 2023 11:01 am |
RNS |
Director/PDMR Shareholding |
| 8th Mar 2023 11:00 am |
RNS |
Director/PDMR Shareholding |
| 6th Mar 2023 7:00 am |
RNS |
Enhertu DESTINY-PanTumor02 shows positive results |
| 1st Mar 2023 3:00 pm |
RNS |
Total Voting Rights |
| 1st Mar 2023 7:00 am |
RNS |
AstraZeneca prices a $2.25bn bond offering |
| 24th Feb 2023 6:15 pm |
RNS |
AstraZeneca prices a EUR1.5bn bond offering |
| 24th Feb 2023 2:05 pm |
RNS |
AstraZeneca acquires CinCor for cardiorenal asset |
| 24th Feb 2023 11:00 am |
RNS |
Director/PDMR Shareholding |
| 23rd Feb 2023 7:00 am |
RNS |
AstraZeneca enters agreement with KYM for CMG901 |
| 22nd Feb 2023 7:10 am |
RNS |
Filing of Form 20-F with SEC |
| 21st Feb 2023 11:00 am |
RNS |
Annual Financial Report |
| 13th Feb 2023 2:01 pm |
RNS |
Director/PDMR Shareholding |
| 13th Feb 2023 2:00 pm |
RNS |
Director/PDMR Shareholding |
| 9th Feb 2023 7:00 am |
RNS |
Final Results |
